Clinical trial
Hepatitis C Antiviral Resistance in African-Americans
NCT00038974 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00038974 |
|---|---|
| Title | Hepatitis C Antiviral Resistance in African-Americans |
| Official title | Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C) |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | National Institute on Minority Health and Health Disparities (NIMHD) NIH National Cancer Institute (NCI) National Center for Advancing Translational Sciences (NCATS) Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | peginterferon alfa-2a, Ribavirin |
| Enrollment | 401 |
| Start date | Aug 1, 2002 |
| Primary completion | Dec 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Jun 10, 2002 |
| Last update posted | Aug 3, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: